Literature DB >> 22923779

Sinonasal teratocarcinosarcoma: a clinical and pathological analysis.

Shudong Yang1, Rongchao Sun, Jiabei Liang, Zhiyi Zhou, Jing Zhou, Jun Rui.   

Abstract

The goal of this study was to assess the pathological and differential diagnoses of sinonasal teratocarcinosarcoma (SNTCS) in order to ultimately improve the diagnosis and treatment of this rare disease. Data from 2 cases of sinonasal teratocarcinosarcoma from the Wuxi People's Hospital (China) were analyzed. The clinical presentation for these patients consisted of nasal obstruction, epistaxis, and headache. On further physical examination, the presence of a polypoid mass was identified and, despite surgery and radiotherapy, both cases experienced recurrence. Histologically, the tumors showed a heterogeneous mixture of components from the 3 germ layers, primitive neuroepithelial elements, diagnostic immature squamous cell nests (clear cell nests), and various epithelial and mesenchymal components. Staining of the different germ layers corresponded with the appropriate immune markers. In case 1, the postradiotherapy resection specimen was completely dominated by a mature teratoma, with a complete absence of the corresponding adenocarcinoma and fibrosarcoma components. To date, this is the first study describing this composition within an SNTCS recurrent tumor. In summary, SNTCS is a rare tumor characterized by the presence of benign and malignant epithelial, mesenchymal, and dysembryomal components. Owing to its heterogeneous histologic appearance, adequate sampling and recognition of all SNTCS components are needed for future diagnosis. Currently, surgical removal, postoperative radiotherapy, and a histology-specific multidrug chemotherapy appear to be the best therapeutic approach. Future individualized therapy may also hold promise.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22923779     DOI: 10.1177/1066896912457202

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  7 in total

1.  Sinonasal Teratocarcinosarcoma- A Rare Tumour not so Rarely Misdiagnosed.

Authors:  Jayalakshmy P Leelamma; Bhavya P Mohan; Aparna Srinivasan
Journal:  Iran J Pathol       Date:  2018

2.  Usefulness of NKX2.2 Immunohistochemistry for Distinguishing Ewing Sarcoma from Other Sinonasal Small Round Blue Cell Tumors.

Authors:  Austin McCuiston; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2017-06-14

3.  Treatment of Sinonasal Teratocarcinosarcoma: A Systematic Review and Survival Analysis.

Authors:  Nikita Chapurin; Douglas J Totten; Justin C Morse; Mohammad S Khurram; Peter C Louis; Robert J Sinard; Naweed I Chowdhury
Journal:  Am J Rhinol Allergy       Date:  2020-09-20       Impact factor: 2.467

Review 4.  Rhabdomyoblastic Differentiation in Head and Neck Malignancies Other Than Rhabdomyosarcoma.

Authors:  Justin A Bishop; Lester D R Thompson; Antonio Cardesa; Leon Barnes; James S Lewis; Asterios Triantafyllou; Henrik Hellquist; Goran Stenman; Jennifer L Hunt; Michelle D Williams; Pieter J Slootweg; Kenneth O Devaney; Douglas R Gnepp; Bruce M Wenig; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck Pathol       Date:  2015-03-11

5.  Sinonasal Teratocarcinosarcoma, a Rare Tumor Involving Both the Nasal Cavity and the Cranial Cavity.

Authors:  Sang Youl Yoon; Ki Su Park; Jeong Hyun Hwang; Seong Hyun Park; Man Hoon Han
Journal:  Brain Tumor Res Treat       Date:  2020-04

Review 6.  Sinonasal teratocarcinosarcoma: a case report and literature review.

Authors:  Yu-Fang Rao; Dan-Ni Cheng; Ke Qiu; Yao Song; Yu Zhao; Deying Gu; Jianjun Ren
Journal:  J Int Med Res       Date:  2020-12       Impact factor: 1.671

7.  Sinonasal teratocarcinosarcoma treated with surgery and proton beam therapy: clinical, histological aspects and differential diagnosis of a new case.

Authors:  Alessia Belotti; Laura Carpenito; Antonio Mario Bulfamante; Alberto Maccari; Gaetano Bulfamante
Journal:  Pathologica       Date:  2021-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.